CARD16 Antibody, HRP conjugated is a specialized immunological reagent designed for the detection and analysis of CARD16 protein (Caspase Recruitment Domain Family, Member 16). This antibody has been affinity-purified and conjugated with Horseradish Peroxidase (HRP), which facilitates direct detection in various immunoassay formats without requiring secondary antibody incubation steps. The HRP conjugation provides a significant advantage in experimental workflows, particularly in Enzyme-Linked Immunosorbent Assay (ELISA) applications .
The antibody specifically targets human CARD16, also known by several alternate names including CARD only domain-containing protein 1, CARD only protein, Caspase-1 inhibitor COP, and Pseudo interleukin-1 beta converting enzyme (Pseudo-ICE) . This target specificity makes the antibody valuable for research into inflammatory pathways and caspase-mediated cellular processes.
Property | Specification |
---|---|
Host | Rabbit |
Clonality | Polyclonal |
Conjugate | Horseradish Peroxidase (HRP) |
Form | Liquid |
Isotype | IgG |
Reactivity | Human |
Purification Method | Antigen Affinity Purified |
Immunogen | Recombinant Human Caspase recruitment domain-containing protein 16 protein (1-197AA) |
Storage Buffer | 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4 |
Storage Conditions | -20°C or -80°C, avoid repeated freeze-thaw cycles |
This particular antibody formulation balances stability, specificity, and convenient laboratory handling .
The antibody targets the full amino acid sequence (1-197AA) of human CARD16 protein. The CARD16 gene is located on human chromosome 11q22 and encodes a protein with a molecular weight of approximately 22.6 kDa. Up to two different isoforms have been reported for this protein, and it demonstrates wide expression across multiple tissue types .
Understanding the target protein's biological role provides important context for the antibody's research applications. CARD16 functions as a crucial regulator in several cellular pathways:
CARD16 serves as a caspase inhibitor that regulates procaspase-1/CASP1 activation. This regulatory function has significant implications for inflammatory processes, particularly in the control of proteolytic maturation of pro-interleukin-1 beta (IL1B) and its subsequent release during inflammation. Research has demonstrated that CARD16 inhibits the release of IL1B in response to lipopolysaccharides (LPS) in monocytes .
CARD16 functions by preventing the activation of caspases CASP1 and CASP4, possibly through disruption of the interaction between CASP1 and RIPK2. Additionally, it participates in NF-kappa-B activation during pro-inflammatory cytokine responses .
The HRP-conjugated CARD16 antibody offers versatility across several experimental applications, with particular advantages in certain methodologies:
Application | Utility | Notes |
---|---|---|
ELISA | Primary application; enables quantitative determination of CARD16 | Competitive enzyme immunoassay technique utilizing polyclonal anti-CARD16 antibody and CARD16-HRP conjugate |
Western Blotting | Detection of CARD16 in protein extracts | Often requires optimization of dilution (typical range: 1:500-1:2000) |
Immunohistochemistry | Visualization of CARD16 in tissue sections | Limited information on optimal dilutions |
The HRP conjugation provides direct enzymatic activity for colorimetric or chemiluminescent detection without requiring secondary antibody steps, streamlining experimental protocols .
When utilizing this antibody in competitive ELISA formats, the assay principle involves competition between sample-derived CARD16 and the CARD16-HRP conjugate for binding to the anti-CARD16 antibody. In this format, the intensity of the color developed is inversely proportional to the CARD16 concentration in the sample, as higher sample CARD16 levels result in fewer binding sites available for the CARD16-HRP conjugate .
Research into CARD16 has revealed important connections to inflammatory and immune processes:
CARD16 has been implicated in the regulation of the NLRP3 inflammasome, a multiprotein complex that plays a critical role in innate immunity and inflammatory responses. Recent studies have shown that mutations in NLRP3 can lead to cryopyrin-associated periodic syndromes (CAPS), characterized by cold-induced inflammation and overproduction of IL-1β .
Research published in eLife (2022) demonstrated that CAPS-associated NLRP3 mutants form cryo-sensitive aggregates that function as scaffolds for inflammasome activation. These findings suggest a potential role for CARD16 in modulating these processes, given its known function as a regulator of caspase-1 activation and IL-1β production .
Recent studies have begun investigating the role of inflammasome components, including CARD16, in cancer development and progression. Analysis of head and neck cancer single-cell RNA sequencing data has identified potential connections between inflammasome regulators and tumor immunity .
The horseradish peroxidase (HRP) conjugation provides specific advantages for antibody applications:
Horseradish peroxidase is an enzyme extensively used in antibody conjugates due to its high catalytic activity and stability. The conjugation process links HRP molecules to the antibody while preserving both the immunological reactivity of the antibody and the enzymatic activity of HRP .
Recent advances in recombinant production of HRP conjugates have improved the consistency and functionality of these reagents. Research published in 2011 demonstrated the possibility of creating functionally active recombinant HRP conjugated with Fab fragments of antibodies, which has opened new avenues for developing highly sensitive immunoassays .
In application, the HRP enzyme catalyzes the oxidation of substrates in the presence of hydrogen peroxide, producing a detectable color change. Common substrates include 3,3',5,5'-tetramethylbenzidine (TMB), which produces a blue color that turns yellow when the reaction is stopped with acidic solution. The intensity of this color is measured spectrophotometrically, typically at 450nm in microplate readers .
Researchers working with CARD16 Antibody, HRP conjugated should consider several practical aspects to optimize results:
Optimal dilutions may vary depending on the specific application and must be determined empirically by each laboratory. For ELISA applications, manufacturers typically provide specific recommendations, while Western blot applications generally require dilutions in the range of 1:500 to 1:2000 .
While the antibody is designed primarily for reactivity with human CARD16, some products may show cross-reactivity with mouse CARD16, which should be considered when designing experiments. Verification of cross-reactivity with the specific product being used is recommended .
CARD16 is a caspase recruitment domain family member 16, a protein with a canonical length of 197 amino acid residues and a mass of 22.6 kDa in humans. It exists in up to 2 different isoforms and is widely expressed across many tissue types. CARD16 is primarily involved in cellular responses to hypoxia and lipopolysaccharides, making it a valuable target for immunological research .
This protein is also known by several synonyms: CARD only domain-containing protein 1, CARD only protein, CARD-only protein 1, caspase recruitment domain-only protein 1, and caspase recruitment domain-containing protein 16. The CARD16 marker can be used to identify Naive Regulatory T Cells, which has significant implications for immunology research .
HRP (Horseradish peroxidase) conjugation involves creating a stable, covalent linkage between HRP enzyme and antibodies. HRP is a 44 kDa glycoprotein containing 6 lysine residues that can be conjugated to antibodies for various applications . For CARD16 antibodies, HRP conjugation provides a sensitive detection system that can be visualized through chromogenic reactions. For example, diaminobenzidine (DAB) in the presence of hydrogen peroxide is converted into a water-insoluble brown pigment, while other substrates like ABTS, TMB, and TMBUS can also be used to measure HRP activity .
This conjugation allows researchers to detect CARD16 protein with high sensitivity in various assays including Western Blot and ELISA, which are common applications for CARD16 antibodies .
CARD16 antibody-HRP conjugates are primarily used in:
Western Blotting: For protein detection and semi-quantitative analysis of CARD16 expression in cell or tissue lysates.
ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative measurement of CARD16 levels in biological samples.
Immunohistochemistry (IHC): Although less common than the above applications, HRP-conjugated antibodies can be used to visualize CARD16 expression in tissue sections .
These applications benefit from direct detection methods using HRP-conjugated primary antibodies, which avoid cross-species reactivity and eliminate additional laborious wash and separation steps, making protocols more efficient and reliable .
The method of conjugation significantly impacts antibody performance. Classical periodate-based conjugation methods rely on generating aldehyde groups by oxidation of carbohydrate moieties on HRP, which then combine with amino groups on antibodies to form Schiff's bases that are stabilized by reduction with sodium cyanoborohydride .
Recent research has demonstrated that incorporating a lyophilization step after HRP activation can dramatically enhance conjugate sensitivity. Experimental data shows that conjugates prepared with this enhanced method can be used at dilutions as high as 1:5000, while conjugates prepared with classical methods require much lower dilutions (approximately 1:25) to achieve the same signal intensity . This represents a statistically significant improvement (p<0.001).
Comparative performance of HRP conjugation methods:
Parameter | Classical Method | Enhanced Method (with Lyophilization) |
---|---|---|
Working Dilution | 1:25 | 1:5000 |
Antigen Detection Limit | Higher | As low as 1.5 ng |
Statistical Significance | - | p<0.001 compared to classical method |
Long-term Storage | Limited | Better stability |
The enhanced sensitivity is attributed to the ability of antibodies to bind more HRP molecules, creating a poly-HRP nature that amplifies signal generation .
When designing experiments with CARD16 antibody-HRP conjugates, researchers should consider:
Buffer Composition: The composition of antibody buffer is crucial for successful conjugation. Common buffer additives can hamper the conjugation process and should be carefully controlled .
Molar Ratios: Optimal results are typically achieved with a 1:4 molar ratio of antibody to HRP. Using precise concentrations (e.g., diluting from stock concentrations of 7.78 mg/ml to 1 mg/ml) for conjugation experiments ensures reproducibility .
Incubation Conditions: Critical parameters include temperature (37°C for initial conjugation, 4°C for reduction steps) and timing (1 hour for initial conjugation, 2 hours for Schiff's base formation) .
Dialysis Procedures: Proper desalting through dialysis against 1× PBS is essential for removing unreacted components and ensuring conjugate purity .
Storage Conditions: For optimal stability, conjugates should be stored at 4°C for up to 6 months or at -20°C for long-term storage, preferably with commercially available stabilizers .
For detecting low abundance CARD16 proteins, researchers should:
Use Enhanced Conjugation Methods: The lyophilization-based method significantly improves sensitivity by enabling the antibody to bind more HRP molecules, creating a poly-HRP effect that amplifies signal detection .
Optimize Substrate Selection: Different HRP substrates offer varying sensitivity levels. TMB (3,3',5,5'-Tetramethylbenzidine) typically provides higher sensitivity than DAB for colorimetric detection, while enhanced chemiluminescent (ECL) substrates offer even greater sensitivity for Western blot applications .
Increase Incubation Times: For low abundance targets, extending the substrate development time can help visualize faint signals, though this must be balanced against increasing background.
Employ Signal Amplification Systems: For extremely low abundance targets, consider tyramide signal amplification (TSA) systems that can increase sensitivity by up to 100-fold compared to conventional detection methods.
Experimental data shows that properly optimized CARD16 antibody-HRP conjugates using the enhanced conjugation method can detect antigen concentrations as low as 1.5 ng, representing a significant improvement over conventional methods .
Common challenges and their solutions include:
Loss of CARD16 Antibody Specificity After Conjugation:
High Background Signal:
Problem: Non-specific binding or excess unconjugated HRP.
Solution: Improve purification through extended dialysis against PBS, optimize blocking agents, and include additional washing steps in protocols.
Loss of HRP Enzymatic Activity:
Poor Reproducibility Between Conjugate Batches:
Validation should include multiple approaches:
Spectrophotometric Analysis: Perform wavelength scans (280-800 nm) to confirm conjugation. Properly conjugated antibody-HRP complexes should show a modified absorption profile compared to unconjugated components, with peaks at both 280 nm (antibody) and 430 nm (HRP), though the 430 nm peak may be smaller in the conjugate due to chemical modification .
SDS-PAGE Analysis: Compare migration patterns of conjugated versus unconjugated components. Successfully conjugated antibody-HRP complexes show limited mobility compared to free antibodies or HRP alone .
Functional Testing: Perform direct ELISA titrations with known positive and negative controls to determine the optimal working dilution and establish a dilution response curve. Compare these results with commercially available conjugates or alternative detection systems .
Specificity Controls: Include appropriate controls such as isotype controls, pre-immune serum controls, and blocking peptide competition assays to confirm that observed signals are specifically due to CARD16 recognition.
When scaling up conjugation procedures:
Maintain Optimal Ratios: The molar ratio of antibody to HRP should remain constant (typically 1:4) regardless of scale. Calculations must be precise when working with larger volumes .
Adjust Reaction Vessel Size: Use appropriately sized vessels that maintain similar surface area-to-volume ratios as smaller scale reactions.
Modify Dialysis Parameters: For larger volumes, increase dialysis time and consider using dialysis cassettes with appropriate molecular weight cut-offs rather than traditional dialysis tubing.
Quality Control Each Batch: Test each batch through spectrophotometric confirmation, SDS-PAGE analysis, and functional assays to ensure consistency.
Aliquot Final Product: After successful large-scale conjugation, divide the final product into working aliquots to avoid repeated freeze-thaw cycles that can degrade both antibody specificity and HRP activity.
Proper interpretation of results requires:
Establish Standard Curves: For quantitative analysis, generate standard curves using recombinant CARD16 protein at known concentrations. The enhanced conjugation method allows detection of antigen concentrations as low as 1.5 ng, enabling more sensitive measurements .
Calculate Signal-to-Noise Ratios: Rather than relying solely on absolute values, calculate signal-to-noise ratios to account for background variation between experiments.
Perform Statistical Analysis: Apply appropriate statistical methods based on experiment design. The p-value threshold for significance should be adjusted based on multiple comparisons when necessary.
Consider Biological Context: Interpret CARD16 expression data in the context of its biological roles in cellular responses to hypoxia and lipopolysaccharides .
Account for Cross-Reactivity: Be aware that CARD16 has homology with related CARD family proteins. Confirm specificity through appropriate controls or orthogonal methods.
Essential controls include:
Positive Controls: Samples with confirmed CARD16 expression, such as relevant cell lines or tissues known to express CARD16.
Negative Controls:
Samples known to lack CARD16 expression
Secondary antibody-only controls (for indirect detection methods)
Isotype controls matched to the CARD16 antibody class and species
Blocking Controls: Pre-incubation of the antibody with recombinant CARD16 protein to demonstrate signal specificity.
Gradient Controls: Serial dilutions of positive samples to establish assay linearity and dynamic range.
Technical Replicates: Multiple measurements of the same sample to assess assay precision.
Biological Replicates: Independent biological samples to account for natural variation in CARD16 expression.
Direct versus indirect detection approaches have distinct advantages:
Parameter | Direct Detection (Primary Ab-HRP) | Indirect Detection (Secondary Ab-HRP) |
---|---|---|
Specificity | High specificity for target | Potential for cross-reactivity |
Sensitivity | Moderate unless using enhanced conjugation | Higher due to signal amplification |
Protocol Length | Shorter (fewer steps) | Longer (additional incubation/wash steps) |
Background | Generally lower | Potentially higher |
Flexibility | Limited to one detection method | Can use various secondary Ab conjugates |
Cost Efficiency | Higher cost per primary antibody | More economical for multiple primary antibodies |
Stability | Conjugation may affect antibody stability | Primary antibody remains unmodified |
For CARD16 detection, the enhanced HRP conjugation method with lyophilization significantly improves the sensitivity of direct detection, making it comparable or superior to indirect methods while maintaining the workflow advantages of fewer steps and reduced cross-reactivity .
The enhanced conjugation method with lyophilization offers several advantages over standard commercial kits:
Superior Sensitivity: The enhanced method allows antibodies to bind more HRP molecules, creating a poly-HRP effect that significantly improves detection sensitivity (1:5000 dilution versus 1:25 for classical methods) .
Longer Shelf-Life: The lyophilization step not only improves conjugation efficiency but also enhances stability, allowing activated HRP to be maintained at 4°C for longer durations .
Lower Antibody Consumption: The increased sensitivity means less conjugate is needed per assay, extending the usable life of precious CARD16 antibody preparations.
Cost-Effectiveness: While initial setup requires more steps than some commercial kits, the enhanced performance and reduced antibody consumption often make this method more economical for long-term research programs.
Customizability: The method allows researchers to optimize specific parameters like molar ratios and incubation conditions based on their specific CARD16 antibody properties.